Initial expierence with Deprescribing in physically active older adults with post-COVID syndrome in Kazakhstan: A Cohort Study Investigating Transition to Simplified Treatment Regimen
DOI:
https://doi.org/10.3329/bjms.v24i1.78729Keywords:
deprescribing, hypertension, older adults, antyhypertensive treatment.Abstract
Background Arterial hypertension (AH) and post-COVID synrome poses a rising challenge in low and middle-income countries, with uncertain prevalence in Kazakhstan’s older adults population.
Objectives This study investigates the effectiveness and safety of transitioning older adults patients (65 and older) from multiple antihypertensive medications to a “single tablet” strategy, aiming to evaluate its effect on patient conidion and identify factors influencing dose adjustments. Design A prospective cohort study with a follow-up of 8 week. Participants There were enrolled 98 patients, categorizing them by age groups 65-74 years and 75 and older. Intervention One-moment isolated deprescribing of hypotensive drugs to “one tablet” therapy. Measurements Endpoints were assessed over three visits in eight weeks, utilizing statistical analysis with significance set at p < 0.05.
Results Older patients exhibited a trend of higher education, lower smoking rates, and lower average weight. Transitioning to a single-tablet strategy led to a significant reduction in hypertensive crises and adverse events. While therapy adherence improved initially, it decreased by 10% by the 8th week. Factors influencing therapy changes were identified through subgroup analysis.
Conclusion This study provides valuable insights into transitioning older adults patients to a “single tablet” strategy, underscoring the importance of personalized approaches based on identified influencing factors.
Bangladesh Journal of Medical Science Vol. 24 No. 01 January’25 Page : 155-163
Downloads
264
294
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Kudabaeva Venera, Mansharipova Almagul, Bolsyn Assel
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish in the Bangladesh Journal of Medical Science agree to the following terms that:
- Authors retain copyright and grant Bangladesh Journal of Medical Science the right of first publication of the work.
Articles in Bangladesh Journal of Medical Science are licensed under a Creative Commons Attribution 4.0 International License CC BY-4.0.This license permits use, distribution and reproduction in any medium, provided the original work is properly cited.- Authors are able to enter into separate, additional contractual arrangements for the distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted to post their work online (e.g., in institutional repositories or on their website) as it can lead to productive exchanges, as well as greater citation of published work.
